Ying Zhu

Dr. Ying Zhu

Chongqing Medical University

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
29 April 2020 in Journal of Bone and Mineral Metabolism
Verified
Journal Article
Closed access
PDF file
WLWenyang Li
Wenyang Li
JHJing Hu
Jing Hu
PJPing Ji
Ping Ji
SZShisheng Zhu
Shisheng Zhu
YZYing Zhu
Ying Zhu

9 October 2025 in Analytica Chimica Acta
Verified
Journal Article
Closed access
ZGZiling Guo
Ziling Guo
SWSibo Wang
Sibo Wang
LWLeihan Wang
Leihan Wang
JWJing Wang
Jing Wang
MLMenghan Li
Menghan Li
YZYing Zhu
Ying Zhu

5 August 2023 in Forensic Science, Medicine and Pathology
Verified
Journal Article
Closed access
PDF file
CZCongcong Zhao
Congcong Zhao
LZLi Zhang
Li Zhang
ZZZhe Zheng
Zhe Zheng
YLYongguo Li
Yongguo Li
XHXiong Hongli
Xiong Hongli
JLJianbo Li
Jianbo Li

30 August 2022 in Genes
Verified
Journal Article
Open access
PDF file
FCFang Cheng
Fang Cheng
YZYujie Zeng
Yujie Zeng
MZMinzhu Zhao
Minzhu Zhao
YZYing Zhu
Ying Zhu
JLJianbo Li
Jianbo Li
RTRenkuan Tang
Renkuan Tang
The detection of early coronary atherosclerosis (ECA) is still a challenge and the mechanism of endothelial dysfunction remains unclear. In the present study, we aimed to identify differentially expressed genes (DEGs) and the regulatory network of miRNAs as well as TFs in dysfunctional endothelium to elucidate the possible pathogenesis of ECA and find new potential markers. The GSE132651 data set of the GEO database was used for the bioinformatic analysis. Principal component analysis (PCA), the identification of DEGs, correlation analysis between significant DEGs, the prediction of regulatory networks of miRNA and transcription factors (TFs), the validation of the selected significant DEGs, and the receiver operating characteristic (ROC) curve analysis as well as area under the curve (AUC) values were performed. We identified ten genes with significantly upregulated signatures and thirteen genes with significantly downregulated signals. Following this, we found twenty-two miRNAs regulating two or more DEGs based on the miRNA–target gene regulatory network. TFs with targets ≥ 10 were E2F1, RBPJ, SSX3, MMS19, POU3F3, HOXB5, and KLF4. Finally, three significant DEGs (TOX, RasGRP3, TSPAN13) were selected to perform validation experiments. Our study identified TOX, RasGRP3, and TSPAN13 in dysfunctional endothelium and provided potential biomarkers as well as new insights into the possible molecular mechanisms of ECA.